Regenxbio Inc’s recent filing unveils that its Director Mills Kenneth T. unloaded Company’s shares for reported $0.16 million on May 12 ’25. In the deal valued at $7.91 per share,20,602 shares were sold. As a result of this transaction, Mills Kenneth T. now holds 475,103 shares worth roughly $4.66 million.
Then, KENNETH MILLS bought 20,602 shares, generating $154,927 in total proceeds.
Before that, VITTAL VASISTA bought 20,041 shares. Regenxbio Inc shares valued at $148,504 were divested by the Officer at a price of $7.41 per share.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock jump 2.94% to $9.81. Over the last five days, the stock has lost -3.16%. Regenxbio Inc shares have risen nearly 26.91% since the year began. Nevertheless, the stocks have fallen -28.71% over the past one year.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-05-15, growing by 1.05 million shares to a total of 6.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 5.25 million shares. There was a rise of 16.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
